Pursuant to the relevant provisions of the SEBI Listing Regulations, Supriya Lifescience has informed that the officials of the company will be interacting with Analyst/Institutional Investors on March 10, 2023 via video conference. The copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company’s website www.supriyalifescience.com. This information is submitted pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
